Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R N JONES

Showing results (501-510 of 945) with videos related to

Pageof 95
Sort By:
Journal of Clinical Microbiology|January 1, 1981
Evaluation of the Sceptor microdilution antibiotic susceptibility testing system: a collaborative investigationR N Jones, C Thornsberry, A L Barry, et al.
Diagnostic Microbiology and Infectious Disease|July 1, 1993
In vitro antimicrobial activity of tioconazole and its concentrations in vaginal fluids following topical (vagistat-1 6.5%) applicationR N Jones, M J Bale, D Hoban, et al.
Diagnostic Microbiology and Infectious Disease|October 29, 1998
Activity of MK-0991 (L-743,872), a new echinocandin, compared with those of LY303366 and four other antifungal agents tested against blood stream isolates of Candida sppF Marco, M A Pfaller, S A Messer, et al.
Diagnostic Microbiology and Infectious Disease|January 1, 1984
Temocillin: in vitro activity against 734 selected clinical isolates, including beta-lactamase-producing strainsP C Fuchs, A L Barry, R N Jones, et al.
Journal of Clinical Microbiology|September 1, 1984
Influence of growth medium on the in vitro activities of second- and third-generation cephalosporins against Streptococcus faecalisD F Sahm, C N Baker, R N Jones, et al.
Journal of Clinical Microbiology|June 1, 1984
Interpretive criteria and tentative quality control limits for apalcillin disk susceptibility testsA L Barry, C Thornsberry, R N Jones, et al.
American Journal of Surgery|April 1, 1987
Antibiotic prophylaxis of 1,036 patients undergoing elective surgical procedures. A prospective, randomized comparative trial of cefazolin, cefoxitin, and cefotaxime in a prepaid medical practiceR N Jones, W Wojeski, J Bakke, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1986
LY164846 in vitro antimicrobial activity testing, including disk diffusion susceptibility tests using 30-microgram disksR N Jones, C Baker, A L Barry, et al.
European Journal of Clinical Microbiology|February 1, 1985
Interpretive criteria for temocillin disk diffusion susceptibility testingP C Fuchs, A L Barry, C Thornsberry, et al.
Diagnostic Microbiology and Infectious Disease|May 1, 1985
Evaluation of in vitro antibacterial activity of enoxacin: comparison with other orally absorbed antimicrobial agents, proposed disk diffusion test interpretive criteria, and quality control limitsP C Fuchs, A L Barry, R N Jones, et al.
Pageof 95

Showing results (501-510 of 945) with videos related to

Sort By:
Pageof 95
Journal of Clinical Microbiology|January 1, 1981
Evaluation of the Sceptor microdilution antibiotic susceptibility testing system: a collaborative investigationR N Jones, C Thornsberry, A L Barry, et al.
Diagnostic Microbiology and Infectious Disease|July 1, 1993
In vitro antimicrobial activity of tioconazole and its concentrations in vaginal fluids following topical (vagistat-1 6.5%) applicationR N Jones, M J Bale, D Hoban, et al.
Diagnostic Microbiology and Infectious Disease|October 29, 1998
Activity of MK-0991 (L-743,872), a new echinocandin, compared with those of LY303366 and four other antifungal agents tested against blood stream isolates of Candida sppF Marco, M A Pfaller, S A Messer, et al.
Diagnostic Microbiology and Infectious Disease|January 1, 1984
Temocillin: in vitro activity against 734 selected clinical isolates, including beta-lactamase-producing strainsP C Fuchs, A L Barry, R N Jones, et al.
Journal of Clinical Microbiology|September 1, 1984
Influence of growth medium on the in vitro activities of second- and third-generation cephalosporins against Streptococcus faecalisD F Sahm, C N Baker, R N Jones, et al.
Journal of Clinical Microbiology|June 1, 1984
Interpretive criteria and tentative quality control limits for apalcillin disk susceptibility testsA L Barry, C Thornsberry, R N Jones, et al.
American Journal of Surgery|April 1, 1987
Antibiotic prophylaxis of 1,036 patients undergoing elective surgical procedures. A prospective, randomized comparative trial of cefazolin, cefoxitin, and cefotaxime in a prepaid medical practiceR N Jones, W Wojeski, J Bakke, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1986
LY164846 in vitro antimicrobial activity testing, including disk diffusion susceptibility tests using 30-microgram disksR N Jones, C Baker, A L Barry, et al.
European Journal of Clinical Microbiology|February 1, 1985
Interpretive criteria for temocillin disk diffusion susceptibility testingP C Fuchs, A L Barry, C Thornsberry, et al.
Diagnostic Microbiology and Infectious Disease|May 1, 1985
Evaluation of in vitro antibacterial activity of enoxacin: comparison with other orally absorbed antimicrobial agents, proposed disk diffusion test interpretive criteria, and quality control limitsP C Fuchs, A L Barry, R N Jones, et al.
Pageof 95